US Patent Issued to IMMUNISBIO on Nov. 18 for "Composition for culturing peripheral blood monocyte-derived regulatory t cell and regulatory T cell culturing method using same" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,534, issued on Nov. 18, was assigned to IMMUNISBIO Co. LTD. (Seo-gu Incheon, South Korea).

"Composition for culturing peripheral blood monocyte-derived regulatory t cell and regulatory T cell culturing method using same" was invented by Sung Hwan Hwang (Gangseo-gu Seoul, South Korea) and Jung Hwa Kang (Gangnam-gu Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition for culturing peripheral blood monocyte-derived regulatory T cells includes at least one antibody selected from the group consisting of anti-CD2, anti-CD3, anti-CD7, anti-CD8, anti-CD28, anti-CD30L, anti-CD40, anti-CD70, anti-CD80, anti-CD83, and anti-CD86; at l...